Cymabay Therapeutics Inc (NASDAQ:CBAY)

8.32
BATS BZX Real-Time Price
As of 1:42pm ET
 0.00 / 0.00%
Today’s Change
1.67
Today|||52-Week Range
8.46
+32.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$660.5M

Company Description

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Contact Information

CymaBay Therapeutics, Inc.
7575 Gateway Boulevard
Newark California 94560
P:(510) 293-8800
Investor Relations:

Employees

Shareholders

Mutual fund holders9.96%
Other institutional60.18%
Individual stakeholders12.92%

Top Executives

Sujal ShahPresident, Chief Executive Officer & Director
Daniel MenoldVice President-Finance
Charles A. McWherterPresident-Research & Development
Dennis D. KimChief Medical Officer
Paul T. QuinlanSecretary & Chief Compliance Officer